Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-30 | Prem A. Lachman. M.D. Dr. Lachman was appointed to the Company’s Board of Directors on March 1, 2021. ... Our Audit Committee is composed of Messrs. Pfenniger (Chairman) and Paganelli, and Drs. Krasno and Lachman. ... The Independent Investment Committee is composed of Drs. Fishel (Chairman), Krasno, and Lachman and Mr. Paganelli. ... Our Succession Committee is composed of Drs. Fishel, Krasno and Lerner, and Mr. Pfenniger. |
| 2022-06-03 | Prem A. Lachman. M.D. Dr. Lachman was appointed to the Company’s Board of Directors on March 1, 2021. ... The following table shows the current members (indicated by an “X” or “Chair”) of each of our standing Board committees: ... Prem A. Lachman, Ph.D. X X X X — ... Fiscal 2021 Director Compensation ... Prem A. Lachman, M.D. 31,563 183,600 215,163 |
| 2023-05-01 | Our Audit Committee is composed of Messrs. Pfenniger (Chairman) and Paganelli, and Drs. Krasno and Lachman. Our Compensation Committee is composed of Drs. Krasno (Chairman), Lachman, and Medel. Our Corporate Governance and Nominating Committee is composed of Mr. Paganelli (Chairman) and Drs. Lachman and Medel. Our Independent Investment Committee is composed of Drs. Lachman (Chairman) and Krasno, and Mr. Paganelli. Our Succession Committee is composed of Messrs. Pfenniger (Chairman) and Paganelli, and Dr. Krasno. |
| 2024-02-29 | Prem A. Lachman, M.D., Director since 2021. Committees: Compensation, Corporate Governance and Nominating, Independent Investment, Succession (Chair). Fiscal 2023 compensation: $92,400. |
| 2025-03-14 | Prem A. Lachman. M.D. Dr. Lachman was appointed to the Company’s Board of Directors in March 2021. ... Our Compensation Committee is currently composed of Drs. Krasno (Chairman), Lachman, and Medel. ... The following table shows the current members (indicated by an “X” or “Chair”) of each of our standing Board committees: ... Prem A. Lachman, M.D. Audit Committee member, Compensation Committee member, Independent Investment Committee Chair. ... Fiscal 2024 Director Compensation: Prem A. Lachman, M.D. 60,000 cash fees, 24,900 stock awards, total 84,900. |
Data sourced from SEC filings. Last updated: 2026-02-03